磷酸化间变型淋巴瘤激酶抗体

磷酸化间变型淋巴瘤激酶抗体Quantity size:

0.1ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated,磷酸化间变型淋巴瘤激酶抗体 or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), LK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011].

磷酸化间变型淋巴瘤激酶抗体Also known as:

ALK (Phospho-Tyr1586); ALK(phospho-Y1586); p-ALK(Tyr1586); p-ALK(Y1586); ALK tyrosine kinase receptor precursor; ALK/EML4 fusion gene, included; ALK/NPM1 fusion gene, included;磷酸化间变型淋巴瘤激酶抗体 anaplastic lymphoma kinase (Ki-1); Anaplastic lymphoma kinase; Anaplastic lymphoma kinase Ki 1; Anaplastic lymphoma kinase Ki1; Anaplastic lymphoma kinase p80 CD 246; CD246; CD246 antigen; EC 2.7.10.1 Ki 1; Ki1; NBLST3; Tcrz; TFG/ALK; ALK_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Chicken, Cow, Horse, .

●

Immunogen: KLH conjugated Synthesised phosphopeptide derived from human ALK around the phosphorylation site of Tyr1586.

●

Predicted Molecular Weight: 174kDa.

磷酸化间变型淋巴瘤激酶抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 

kl611Hu01POTE锚蛋白域家族成员G(POTEG)多克隆抗体Polyclonal Antibody to POTE Ankyrin Domain Family, Member G (POTEG)

kl635Hu01牙骨质蛋白1(CEMP1)多克隆抗体Polyclonal Antibody to Cementum Protein 1 (CEMP1)

kl658Hu01防御素β103B(DEFβ103B)多克隆抗体Polyclonal Antibody to Defensin Beta 103B (DEFB103B)

kl667Hu01结肠癌转移关联基因1(MACC1)多克隆抗体Polyclonal Antibody to Metastasis Associated In Colon Cancer 1 (MACC1)

kl679Hu01RAS癌基因家族成员RAB37(RAB37)多克隆抗体Polyclonal Antibody to RAB37, Member RAS Oncogene Family (RAB37)

kl762Hu01干扰素诱导内质网关联病毒抑制蛋白(Viperin)多克隆抗体Polyclonal Antibody to Virus Inhibitory Protein (Viperin)

kl767Hu01锌指同源框蛋白4(ZFHX4)多克隆抗体Polyclonal Antibody to Zinc Finger Homeobox Protein 4 (ZFHX4)

kl802Hu01结侧蛋白(JN)多克隆抗体Polyclonal Antibody to Juxtanodin (JN)

kl893Hu01含RNA结合冷休克域蛋白E1(CSDE1)多克隆抗体Polyclonal Antibody to Cold Shock Domain Containing Protein E1, RNA Binding (CSDE1)

kl021Hu01RNA结合基元蛋白20(RBM20)多克隆抗体Polyclonal Antibody to RNA Binding Motif Protein 20 (RBM20)

kl048Hu01HtrA丝氨酸肽酶4(HTRA4)多克隆抗体Polyclonal Antibody to HtrA Serine Peptidase 4 (HTRA4)

kl221Hu01Dermokine蛋白(DMKN)多克隆抗体Polyclonal Antibody to Dermokine (DMKN)

kl237Hu01肝细胞癌相关蛋白1(HCRP1)多克隆抗体Polyclonal Antibody to Heklocellular Carcinoma Related Protein 1 (HCRP1)

Optimal working dilutions must be determined by the end user.